The origin of cancer stem cells Y Bu, D Cao Frontiers in Bioscience 4, 819-830, 2012 | 122 | 2012 |
The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-κB from Toll-like receptor 4 W Dong, Y Liu, J Peng, L Chen, T Zou, H Xiao, Z Liu, W Li, Y Bu, Y Qi Journal of Biological Chemistry 281 (36), 26029-26040, 2006 | 121 | 2006 |
AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker J Ma, DX Luo, C Huang, Y Shen, Y Bu, S Markwell, J Gao, J Liu, X Zu, ... International journal of cancer 131 (6), E862-E871, 2012 | 113 | 2012 |
A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival Yiwen Bu, Akihiro Yoshida, Nilesh Chitnis, Brian J. Altman, Feven Tameire ... Nature Cell Biology, 2017 | 104* | 2017 |
PERK integrates oncogenic signaling and cell survival during cancer development Y Bu, JA Diehl Journal of cellular physiology 231 (10), 2088-2096, 2016 | 87 | 2016 |
miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis Z Xu, Y Bu, N Chitnis, CK Koumenis, SY Fuchs, JA Diehl NATURE COMMUNICATIONS, 2016 | 79 | 2016 |
Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells Z Liu, R Yan, A Al-Salman, Y Shen, Y Bu, J Ma, DX Luo, C Huang, Y Jiang, ... Biochemical Journal 442 (2), 273-282, 2012 | 72 | 2012 |
Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling C Wang, CX Xu, Y Bu, KM Bottum, SA Tischkau Carcinogenesis 35 (3), 703-713, 2014 | 57 | 2014 |
Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice Y Shen, J Ma, R Yan, H Ling, X Li, W Yang, J Gao, C Huang, Y Bu, Y Cao, ... Clinical cancer research 21 (6), 1466-1476, 2015 | 56 | 2015 |
A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor‐suppressive role of Ser536 phosphorylation Yiwen Bu, Xiaoning Li, Yingchun He, Chenfei Huang, Yi Shen, Yu Cao, Dan ... International Journal of Cancer 138 (5), 1186-98, 2016 | 40 | 2016 |
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors A Yoshida, Y Bu, S Qie, J Wrangle, ER Camp, ES Hazard, G Hardiman, ... Science advances 5 (9), eaax6352, 2019 | 39 | 2019 |
AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway C Huang, S Verhulst, Y Shen, Y Bu, Y Cao, Y He, Y Wang, D Huang, ... Oncotarget, 2016 | 39 | 2016 |
AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells C Huang, Z Cao, J Ma, Y Shen, Y Bu, R Khoshaba, G Shi, D Huang, ... Molecular carcinogenesis 57 (10), 1300-1310, 2018 | 38 | 2018 |
p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration Y Cao, M Lin, Y Bu, H Ling, Y He, C Huang, Y Shen, B Song, D Cao International journal of oncology 50 (5), 1671-1682, 2017 | 36 | 2017 |
Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes D Luo, Y Bu, J Ma, S Rajput, Y He, G Cai, DF Liao, D Cao Journal of Biological Chemistry 288 (51), 36733-36740, 2013 | 29 | 2013 |
Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance Y Bu, G Cai, Y Shen, C Huang, X Zeng, Y Cao, C Cai, Y Wang, D Huang, ... Cancer Letters 383 (2), 261-271, 2016 | 27 | 2016 |
Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathway J Lin, X Jin, Y Bu, D Cao, N Zhang, S Li, Q Sun, C Tan, C Gao, Y Jiang Organic & Biomolecular Chemistry 10 (48), 9734-9746, 2012 | 22 | 2012 |
MACMIC reveals a dual role of CTCF in epigenetic regulation of cell identity genes G Wang, B Xia, M Zhou, J Lv, D Zhao, Y Li, Y Bu, X Wang, JP Cooke, ... Genomics, Proteomics and Bioinformatics 19 (1), 140-153, 2021 | 5 | 2021 |
Stressing Out Melanoma with an anti-GRP78 compound Y Bu, JA Diehl Pigment Cell & Melanoma Research, 2016 | 4 | 2016 |
Abstract A01: ER stress disrupts circadian rhythms via miR-211 Y Bu, JA Diehl Cancer Research 76 (6_Supplement), A01-A01, 2016 | 1 | 2016 |